Caribou Biosciences, Inc. (CRBU) Net Income (Loss) Attributable to Parent USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Caribou Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2024.
  • Caribou Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$41.2 M, a 47% decline year-over-year.
  • Caribou Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$115 M, a 6.35% decline year-over-year.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102 M, a 2.66% decline from 2022.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$99.4 M, a 48.6% decline from 2021.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$66.9 M, a 95.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$115 M -$41.2 M -$13.2 M -47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$102 M -$34.5 M -$7.52 M -27.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$94.6 M -$10 M +$16.6 M +62.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$111 M -$29.5 M -$2.82 M -10.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 -$108 M -$28 M -$8.96 M -46.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$99.4 M -$27 M -$8.51 M -46.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$90.9 M -$26.6 M -$5.67 M -27% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$85.2 M -$26.7 M -$12.4 M -86.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$72.9 M -$19.1 M -$5.93 M -45.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$66.9 M -$18.5 M -$3.78 M -25.7% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-21
Q3 2021 -$63.1 M -$21 M -$13 M -164% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$50.1 M -$14.3 M -$12.4 M -664% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$37.7 M -$13.2 M -$3.36 M -34.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$34.3 M -$14.7 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$7.93 M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-21
Q2 2020 -$1.87 M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-21
Q1 2020 -$9.8 M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.